Hanmi Pharm. Co., Ltd.'s (KRX:128940) Share Price Not Quite Adding Up
Apr 22
South Korean (KOSPI) Pharma Industry Analysis
UpdatedApr 22, 2024
DataAggregated Company Financials
Companies98
- 7D-3.8%
- 3M-3.2%
- 1Y3.6%
- YTD-11.5%
Over the last 7 days, the Pharma industry has dropped 3.8%, driven by a pullback from Samil PharmaceuticalLtd of 6.3%. Meanwhile, Yuhan actually outperformed within the industry, gaining 5.5% in the last week. In the past year, the industry has gained 3.6%. Earnings are forecast to grow by 34% annually.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 23 Apr 2024 | ₩49.7t | ₩29.4t | ₩922.9b | 16.2x | 53.9x | 1.7x |
| Thu, 21 Mar 2024 | ₩54.3t | ₩29.7t | ₩767.2b | 21.5x | 70.7x | 1.8x |
| Sat, 17 Feb 2024 | ₩51.7t | ₩29.6t | ₩593.1b | 21x | 87.2x | 1.8x |
| Mon, 15 Jan 2024 | ₩53.6t | ₩29.6t | ₩588.5b | 23.1x | 91.1x | 1.8x |
| Wed, 13 Dec 2023 | ₩50.6t | ₩29.6t | ₩588.2b | 21.7x | 86.1x | 1.7x |
| Fri, 10 Nov 2023 | ₩48.6t | ₩29.3t | ₩683.3b | 16.5x | 71.1x | 1.7x |
| Sun, 08 Oct 2023 | ₩51.0t | ₩29.3t | ₩683.3b | 17x | 74.7x | 1.7x |
| Tue, 05 Sep 2023 | ₩50.0t | ₩29.3t | ₩683.9b | 15.7x | 73.1x | 1.7x |
| Thu, 03 Aug 2023 | ₩50.1t | ₩28.8t | ₩884.1b | 21.9x | 56.7x | 1.7x |
| Sat, 01 Jul 2023 | ₩47.5t | ₩28.9t | ₩908.3b | 20.8x | 52.3x | 1.6x |
| Mon, 29 May 2023 | ₩47.7t | ₩28.9t | ₩902.3b | 22.6x | 52.9x | 1.7x |
| Wed, 26 Apr 2023 | ₩47.3t | ₩28.5t | ₩602.7b | 20.6x | 78.5x | 1.7x |
| Fri, 24 Mar 2023 | ₩44.2t | ₩28.2t | ₩651.8b | 17.9x | 67.8x | 1.6x |
| Sun, 19 Feb 2023 | ₩44.5t | ₩27.7t | ₩743.5b | 20.2x | 59.8x | 1.6x |
| Tue, 17 Jan 2023 | ₩45.6t | ₩28.0t | ₩770.2b | 20x | 59.3x | 1.6x |
| Thu, 15 Dec 2022 | ₩48.4t | ₩28.0t | ₩770.2b | 20.2x | 62.9x | 1.7x |
| Sat, 12 Nov 2022 | ₩44.4t | ₩27.2t | ₩695.9b | 20.8x | 63.8x | 1.6x |
| Mon, 10 Oct 2022 | ₩41.7t | ₩27.2t | ₩694.8b | 20.6x | 60x | 1.5x |
| Wed, 07 Sep 2022 | ₩47.8t | ₩27.5t | ₩725.5b | 22.3x | 65.9x | 1.7x |
| Fri, 05 Aug 2022 | ₩51.2t | ₩26.7t | ₩475.9b | 23.2x | 107.5x | 1.9x |
| Sun, 03 Jul 2022 | ₩46.3t | ₩26.7t | ₩475.9b | 20.2x | 97.4x | 1.7x |
| Tue, 31 May 2022 | ₩54.1t | ₩26.6t | ₩446.7b | 24.3x | 121.1x | 2x |
| Thu, 28 Apr 2022 | ₩56.0t | ₩26.1t | ₩674.3b | 27.1x | 83.1x | 2.2x |
| Sat, 26 Mar 2022 | ₩57.3t | ₩25.7t | ₩705.9b | 24.1x | 81.1x | 2.2x |
| Mon, 21 Feb 2022 | ₩52.7t | ₩25.0t | ₩934.5b | 23x | 56.4x | 2.1x |
| Wed, 19 Jan 2022 | ₩54.1t | ₩25.0t | ₩934.5b | 22.2x | 57.9x | 2.2x |
| Fri, 17 Dec 2021 | ₩61.6t | ₩25.0t | ₩934.5b | 26.4x | 66x | 2.5x |
| Sun, 14 Nov 2021 | ₩59.7t | ₩24.7t | ₩875.4b | 23.6x | 68.2x | 2.4x |
| Tue, 12 Oct 2021 | ₩62.4t | ₩24.7t | ₩876.1b | 23.7x | 71.2x | 2.5x |
| Thu, 09 Sep 2021 | ₩71.2t | ₩26.0t | ₩960.6b | 38.3x | 74.1x | 2.7x |
| Sat, 07 Aug 2021 | ₩72.1t | ₩25.3t | ₩928.3b | 41.5x | 77.7x | 2.8x |
| Fri, 30 Apr 2021 | ₩69.3t | ₩24.9t | ₩915.5b | 34.8x | 75.7x | 2.8x |
Price to Earnings Ratio
75.7x
Current Industry PE
- Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 53.9x which is lower than its 3-year average PE of 72.6x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -3.28% | |
| Healthcare | -2.25% | |
| Pharma | -3.76% | |
| Pharma | -3.76% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A000100 Yuhan | ₩73.10k | 5.5% +₩283.9b | 35.8% | PE40.1x | |
| A326030 SK Biopharmaceuticals | ₩84.00k | 2.9% +₩188.0b | 20.5% | PS18.5x | |
| A128940 Hanmi Pharm | ₩313.00k | 4.3% +₩164.9b | 4.2% | PE27.2x | |
| A195940 HK inno.N | ₩40.20k | 16.4% +₩160.1b | 26.0% | n/a | |
| A039200 Oscotec | ₩31.20k | 12.0% +₩128.0b | 39.0% | PS240.7x |
